First-of-its-Kind Data Underscore Importance of Early Use of Drug Therapy as a Primary Prevention, Especially for Those Living with Diabetes SAN DIEGO, June 24, 2023 /PRNewswire/ — Today, a new trial revealed data on the effects of bempedoic acid – a non-statin cholesterol-lowering drug…

NEW YORK, June 24, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE: CRL) between May 5, 2020 and February 21, 2023, both dates inclusive (the “Class Period”), of the…

NEW YORK, June 24, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between February 28, 2023 and March 17, 2023, both dates inclusive (the “Class Period”), of the important July 25,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.